Stroke
Conditions
Interventions
control group:Routine rehabilitation therapy + pseudomagnetic stimulation therapy + pseudomirror therapy
Mirror therapy group:Routine rehabilitation therapy + pseudomagnetic stimulation therapy + mirror therapy
Magnetic stimulation group:Routine rehabilitation therapy + repeated transcranial magnetic stimulation therapy + pseudomirror therapy
Combined treatment group:Routine rehabilitation therapy + repeated transcranial magnetic stimulation therapy + mirror therapy
Sponsors
Jinshan Hospital Affiliated to Fudan University
Eligibility
Sex/Gender
All
Age
20 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for "stroke" formulated by the Fourth National Academic Conference on Cerebrovascular Diseases, and make a clear diagnosis through cranial MRI or CT examination; 2. Gender unlimited, aged 20-75 years old; 3. The first occurrence of stroke or previous occurrence of lacunar infarction without any sequelae; 4. Within 3 months after onset, the condition has remained stable within the past 1 week; 5. Stroke patients with clear consciousness, no obvious cognitive impairment, and a Simplified Cognitive State Examination (MMSE) score of>=24, who can cooperate with assessment and treatment; 6. Unilateral limb paralysis, Brunnstrom stage II-IV for the affected upper limb and hand, modified Asworth grade for muscle tone<=2; 7. Sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Women of childbearing age who wear pacemakers, have metal implants or other metal implants inside the body, or have skull defects, epilepsy, pregnancy, lactation, or have not taken reliable contraceptive measures; 2. Patients with severe systemic diseases who are unable to participate in the study: those with severe respiratory, heart, liver, kidney, endocrine, and hematopoietic system diseases, such as congestive heart failure, arrhythmia, and uncontrolled hypertension; 3. Significant disability or other diseases that affect upper limb movement: severe infection, contracture, joint surgery, amputation, fracture, rheumatism or rheumatoid arthritis of the upper limb; 4. Individuals with severe speech, visual, hearing impairment (such as deaf mute) or mental disorders that affect examination and treatment; 5. Patients who have recently participated in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fugl-Meyer Assessment Upper Extremity Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Action Research Arm Test;Rest Motor Threshold;central motor conduction time;motion envoked potential; | — |
Countries
China
Contacts
Public ContactBenmei Chen
Jinshan Hospital Affiliated to Fudan University
Outcome results
None listed